| Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site S Chen, JL Wu, Y Liang, YG Tang, HX Song, LL Wu, YF Xing, N Yan, ... Cancer cell 39 (2), 225-239. e8, 2021 | 170 | 2021 |
| AmyM, a novel maltohexaose-forming α-amylase from Corallococcus sp. strain EGB Z Li, J Wu, B Zhang, F Wang, X Ye, Y Huang, Q Huang, Z Cui Applied and environmental microbiology 81 (6), 1977-1987, 2015 | 56 | 2015 |
| Novel maltogenic amylase CoMA from Corallococcus sp. strain EGB catalyzes the conversion of maltooligosaccharides and soluble starch to maltose J Zhou, Z Li, H Zhang, J Wu, X Ye, W Dong, M Jiang, Y Huang, Z Cui Applied and Environmental Microbiology 84 (14), e00152-18, 2018 | 31 | 2018 |
| Functional analysis of a novel β-(1, 3)-glucanase from Corallococcus sp. strain EGB containing a fascin-like module J Zhou, Z Li, J Wu, L Li, D Li, X Ye, X Luo, Y Huang, Z Cui, H Cao Applied and Environmental Microbiology 83 (16), e01016-17, 2017 | 26 | 2017 |
| The Regulation of para-Nitrophenol Degradation in Pseudomonas putida DLL-E4 Q Chen, H Tu, X Luo, B Zhang, F Huang, Z Li, J Wang, W Shen, J Wu, ... PloS one 11 (5), e0155485, 2016 | 26 | 2016 |
| CDK9 inhibitors reactivate p53 by downregulating iASPP J Wu, Y Liang, Y Tan, Y Tang, H Song, Z Wang, Y Li, M Lu Cellular Signalling 67, 109508, 2020 | 25 | 2020 |
| Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties H Song, J Wu, Y Tang, Y Dai, X Xiang, Y Li, L Wu, J Wu, Y Liang, Y Xing, ... Science Translational Medicine 15 (690), eabn9155, 2023 | 22 | 2023 |
| iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition S Chen, J Wu, S Zhong, Y Li, P Zhang, J Ma, J Ren, Y Tan, Y Wang, ... Proceedings of the National Academy of Sciences 116 (35), 17470-17479, 2019 | 22 | 2019 |
| Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations Y Tang, H Song, Z Wang, S Xiao, X Xiang, H Zhan, L Wu, J Wu, Y Xing, ... Cell reports 39 (2), 2022 | 20 | 2022 |
| Cloning, heterologous expression, and enzymatic characterization of a novel glucoamylase GlucaM from Corallococcus sp. strain EGB Z Li, K Ji, W Dong, X Ye, J Wu, J Zhou, F Wang, Q Chen, L Fu, S Li, ... Protein Expression and Purification 129, 122-127, 2017 | 19 | 2017 |
| Efficient Production and Characterization of Maltohexaose‐Forming α‐Amylase AmyM Secreted From the Methylotrophic Yeast Pichia pastoris L Zhoukun, W Jiale, W Ting, Z Wenwen, Q Yan, H Yan, C Zhongli Starch‐Stärke 70 (11-12), 1700312, 2018 | 16 | 2018 |
| Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation N Yan, Y Li, Y Xing, J Wu, J Li, Y Liang, Y Tang, Z Wang, H Song, H Wang, ... EMBO reports 23 (6), e54147, 2022 | 12 | 2022 |
| Three optimized assays for the evaluation of compounds that can rescue p53 mutants J Wu, H Song, Z Wang, M Lu STAR protocols 2 (3), 100688, 2021 | 10 | 2021 |
| A prognostic model for acute myeloid leukemia based on IL-2/STAT5 pathway-related genes Y Tang, S Xiao, Z Wang, Y Liang, Y Xing, J Wu, M Lu Frontiers in Oncology 12, 785899, 2022 | 6 | 2022 |
| Molecular cloning and characterization of a novel GH13 saccharifying α‐amylase AmyC from Corallococcus sp. EGB J Wu, B Xia, Z Li, X Ye, Q Chen, W Dong, J Zhou, Y Huang, Z Cui Starch‐Stärke 67 (9-10), 810-819, 2015 | 5 | 2015 |
| Characterization of the generic mutant p53-rescue compounds in a broad range of assays S Xiao, F Shi, H Song, J Cui, D Zheng, H Zhang, K Tan, J Wu, X Chen, ... Cancer Cell 42 (3), 325-327, 2024 | 4 | 2024 |
| AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity Y Liang, Q An, H Song, Y Tang, S Xiao, J Wu, N Yan, B Yu, X Cao, M Lu Journal of Medicinal Chemistry 66 (24), 16579-16596, 2023 | 4 | 2023 |
| Broad-spectrum rescue compounds for structural p53 mutations: perspective on ‘Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site’ JL Wu, S Chen, M Lu Journal of Molecular Cell Biology 13 (2), 155-157, 2021 | 3 | 2021 |
| MDM2‐Targeting Reassembly Peptide (TRAP) Nanoparticles for p53‐Based Cancer Therapy F Li, D Chen, Q Sun, J Wu, Y Gan, KW Leong, XJ Liang Advanced Materials 35 (45), 2305164, 2023 | 2 | 2023 |
| Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells J Wu, Y Li, J Wu, H Song, Y Tang, N Yan, L Wu, S Zhang, CK Chang, ... Clinical and Translational Medicine 11 (11), 2021 | 2 | 2021 |
